A federal jury decided Wednesday that Bayer must pay more than $80 million to a California man diagnosed with non-Hodgkin lymphoma after the panel determined there was a credible connection between the plaintiff’s prolonged exposure to the company’s Roundup weedkiller and his cancer.

The decision, announced after the six-person jury deliberated for nearly two days, marked the second major jury award in a case that centered on the health risks of Bayer’s Roundup weedkillers, which contains the chemical glyphosate. Bayer acquired Monsanto’s glyphosate-based products when it purchased the company in a $66 billion deal finalized last year.

Bayer was ordered to pay $75 million in punitive damages and about $5 million in compensatory damages, along with $200,000 in medical costs.